| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f550294f26d4b8aae8fb282ea2bf8ed9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1676
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 |
| filingDate |
2006-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a3b92d23cdcd58e0fd010c41436e3b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab043e2acc06117a5381ebf259e0e86a |
| publicationDate |
2010-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010009005-A1 |
| titleOfInvention |
Novel acetysalicylic acid formulations |
| abstract |
The invention relates to pharmaceutical compositions of acetylsalicylic acid-based microcapsules to selectively inhibit the COX in the portal vein and/or in the liver to reduce the production of thromboxane. Further, the pharmaceutical composition minimizes COX inhibition in the systemic circulation to optimize the inhibition of platelet aggregation. Certain embodiments also address methods of prevention and/or treatment of these diseases, using these oral compositions such as enhancing the safety of antithrombotic treatments. Other embodiments contemplate oral pharmaceutical compositions that combine acetylsalicylic acid with anti-platelet aggregation drugs, without inducing gastric side effects. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015284799-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015164818-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011206667-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014024623-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017184487-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11697850-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11696894-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020248262-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017184489-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10550433-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017335394-A1 |
| priorityDate |
2005-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |